Oxford Lab Technologies Confidential Materials Access Agreement
- Effective date
- November 3, 2026
Version: 1.0
1. Acceptance
1.1 Binding Agreement
This Confidential Materials Access Agreement (the "Agreement") is a legally binding agreement between:
- (a)
Oxford Lab Technologies Ltd (the Company); and
- (b)
1.2 Acceptance by Access
By:
- (a)
accessing;
- (b)
viewing;
- (c)
downloading;
- (d)
receiving;
- (e)
opening;
- (f)
reviewing; or
- (g)
continuing to access
1.3 Acceptance on Behalf of Organisations
Where the Recipient accesses Confidential Materials on behalf of:
- (a)
a company;
- (b)
university;
- (c)
government organisation;
- (d)
laboratory;
- (e)
research institution;
- (f)
partnership; or
- (g)
other legal entity,
the individual accepting this Agreement represents and warrants that they have authority to bind that organisation.
2. Definitions
Company means Oxford Lab Technologies Ltd and any associated company, subsidiary, successor or permitted assign.
Agreement means this Confidential Materials Access Agreement together with any amendments, updates, supplements or replacements made in accordance with its terms.
Recipient means the person or entity accessing Confidential Materials.
Recipient Representatives means the Recipient's employees, officers, consultants, contractors, professional advisers and any other persons acting on its behalf.
Confidential Materials means any information, content or material provided, displayed, disclosed or made available by the Company, whether before or after acceptance of this Agreement, including:
- (a)
videos;
- (b)
demonstrations;
- (c)
presentations;
- (d)
training materials;
- (e)
photographs;
- (f)
screenshots;
- (g)
drawings;
- (h)
specifications;
- (i)
designs;
- (j)
reports;
- (k)
software;
- (l)
source code;
- (m)
object code;
- (n)
firmware;
- (o)
know-how;
- (p)
trade secrets;
- (q)
technical information;
- (r)
commercial information;
- (s)
pricing information;
- (t)
product roadmaps;
- (u)
business plans;
- (v)
prototypes;
- (w)
research;
- (x)
development information; and
- (y)
any related material.
Intellectual Property means any patent, copyright, moral right, trade mark, database right, trade secret, know-how and any other intellectual property right whether registered or unregistered.
3. Purpose
3.1 Permitted Purpose
The Confidential Materials are disclosed solely for:
- (a)
evaluation;
- (b)
assessment;
- (c)
due diligence;
- (d)
procurement evaluation;
- (e)
technical evaluation;
- (f)
research evaluation;
- (g)
training; or
- (h)
determining whether to enter into a commercial relationship with the Company.
3.2 No Other Purpose
The Recipient shall not use any Confidential Materials for any other purpose without prior written consent from the Company.
4. Confidentiality Obligations
4.1 Confidential Treatment
The Recipient shall ensure that it and its Recipient Representatives:
- (a)
keep the Confidential Materials confidential;
- (b)
protect the Confidential Materials using at least reasonable care;
- (c)
prevent unauthorised disclosure;
- (d)
prevent unauthorised access; and
- (e)
use the Confidential Materials only for the permitted purpose.
4.2 Limited Access
The Recipient may disclose Confidential Materials only to its Recipient Representatives who:
- (a)
have a legitimate need to know;
- (b)
are informed of the confidential nature of the information; and
- (c)
are bound by confidentiality obligations no less protective than those contained in this Agreement.
4.3 Responsibility for Representatives
The Recipient remains responsible for any act or omission of any person to whom Confidential Materials are disclosed.
5. Restrictions
5.1 No Disclosure
Neither the Recipient nor any Recipient Representatives shall publish, share, distribute or otherwise disclose Confidential Materials to any third party except as expressly permitted by this Agreement.
5.2 No Copying
Neither the Recipient nor any Recipient Representatives shall copy, reproduce, record, photograph, download, screen-capture or store Confidential Materials except where reasonably necessary for the permitted purpose.
5.3 No Reverse Engineering
Neither the Recipient nor any Recipient Representatives shall:
- (a)
reverse engineer;
- (b)
decompile;
- (c)
disassemble;
- (d)
analyse;
- (e)
derive; or
- (f)
attempt to discover
the composition, operation, implementation, design or functionality of any software, hardware or technology disclosed by the Company.
5.4 No Competitive Use
Neither the Recipient nor any Recipient Representatives shall use Confidential Materials for the purpose of:
- (a)
developing competing products;
- (b)
developing competing services;
- (c)
benchmarking;
- (d)
comparative analysis;
- (e)
competitive intelligence; or
- (f)
assisting any competitor.
6. Intellectual Property
6.1 Ownership
All Intellectual Property rights in the Confidential Materials remain vested in the Company.
6.2 No Licence
No licence, assignment, transfer, ownership right or other right is granted except the limited right to access the Confidential Materials for the permitted purpose.
6.3 Feedback
Any feedback, suggestions or recommendations provided by or on behalf of the Recipient or its Recipient Representatives may be used by the Company without restriction or compensation.
7. Compelled Disclosure
7.1 Required Disclosure
Where disclosure is required by:
- (a)
law;
- (b)
regulation;
- (c)
court order;
- (d)
governmental authority; or
- (e)
regulatory authority,
the Recipient may disclose only that part of the Confidential Materials required to comply.
7.2 Notice Requirement
Where permitted by law, the Recipient shall promptly notify the Company before such disclosure.
7.3 Disclosure Requests
The Recipient shall promptly notify the Company of any:
- (a)
freedom of information request;
- (b)
public-records request;
- (c)
transparency request; or
- (d)
similar disclosure request
that may affect the Confidential Materials.
The Recipient shall take all reasonable steps permitted by law to protect the Confidential Materials from disclosure.
8. Exclusions
8.1 Excluded Information
Information shall not be regarded as Confidential Materials to the extent the Recipient can demonstrate that such information:
- (a)
was already lawfully known;
- (b)
becomes publicly available other than through a breach of this Agreement;
- (c)
is lawfully obtained from an independent third party without a duty of confidentiality; or
- (d)
is independently developed without reference to the Confidential Materials.
9. Return and Destruction
9.1 Company Request
Upon request by the Company, the Recipient shall ensure that it and its Recipient Representatives promptly:
- (a)
cease use of the Confidential Materials;
- (b)
return them; or
- (c)
destroy them.
9.2 Residual Copies
The Recipient may retain copies only where required by:
- (a)
applicable law;
- (b)
regulation;
- (c)
court order; or
- (d)
bona fide backup systems,
provided continuing confidentiality obligations remain in force.
10. Injunctive Relief
10.1 Equitable Remedies
The Recipient acknowledges that monetary damages alone may be an insufficient remedy for breach of this Agreement.
The Company shall be entitled to seek:
- (a)
injunctions;
- (b)
specific performance; and
- (c)
other equitable relief,
without prejudice to any other rights or remedies.
11. Duration
11.1 Confidentiality Survival
The obligations contained in this Agreement shall continue:
- (a)
for twenty (20) years after disclosure; or
- (b)
for trade secrets, for so long as the information remains a trade secret,
whichever period is longer.
12. Liability
12.1 No Warranty
The Confidential Materials are provided on an "as is" basis.
The Company gives no warranty as to:
- (a)
accuracy;
- (b)
completeness;
- (c)
suitability;
- (d)
fitness for purpose; or
- (e)
commercial usefulness.
12.2 No Obligation
Nothing in this Agreement requires the Company to:
- (a)
continue discussions;
- (b)
enter into any transaction;
- (c)
supply any goods;
- (d)
provide any services; or
- (e)
continue providing access.
13. General
13.1 Entire Agreement
This Agreement constitutes the entire agreement relating to the Confidential Materials.
13.2 Severability
If any provision is invalid or unenforceable, the remaining provisions shall remain effective.
13.3 Assignment
The Company may assign, transfer or novate this Agreement.
The Recipient may not do so without written consent.
13.4 Governing Law
This Agreement shall be governed by the laws of England and Wales.
13.5 Jurisdiction
The courts of England and Wales shall have exclusive jurisdiction except that the Company may bring proceedings in any court of competent jurisdiction where the Recipient or its assets are located.

